Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
TNXP on Nasdaq
Shares outstanding
12,754,910
Price per share
$15.62
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,353,724
Total reported value
$56,868,048
% of total 13F portfolios
0%
Share change
+966,513
Value change
+$22,987,379
Number of holders
58
Price from insider filings
$15.62
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Point72 Asset Management, L.P. 9.2% $19,884,434 1,235,058 Point72 Asset Management, L.P. 29 Dec 2025
BlackRock, Inc. 6.7% -14% $13,348,524 +$2,726,362 854,579 +26% BlackRock, Inc. 31 Dec 2025
VANGUARD GROUP INC 6.4% $13,456,081 556,957 The Vanguard Group 30 Sep 2025

As of 30 Sep 2025, 58 institutional investors reported holding 2,353,724 shares of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP). This represents 18% of the company’s total 12,754,910 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) together control 18% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 5.3% 681,530 +62% 0% $16,465,764
VANGUARD GROUP INC 4.4% 556,957 +238% 0% $13,456,081
GEODE CAPITAL MANAGEMENT, LLC 1.6% 200,934 +15% 0% $4,855,283
NORTHERN TRUST CORP 1.3% 169,687 +3.5% 0% $4,099,638
STATE STREET CORP 1.2% 152,544 +24% 0% $3,685,463
CAPITAL FUND MANAGEMENT S.A. 0.49% 62,948 0.02% $1,520,823
MILLENNIUM MANAGEMENT LLC 0.41% 52,731 +494% 0% $1,273,981
UBS Group AG 0.4% 51,581 +130% 0% $1,246,197
FMR LLC 0.36% 45,466 +257% 0% $1,098,459
Susquehanna Portfolio Strategies, LLC 0.33% 41,454 0% 0.02% $1,001,529
Squarepoint Ops LLC 0.25% 31,633 0% $764,253
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.21% 26,789 +23% 0% $647,222
WELLINGTON MANAGEMENT GROUP LLP 0.21% 26,465 0% $639,395
XTX Topco Ltd 0.16% 20,296 0.03% $490,351
Bank of New York Mellon Corp 0.16% 20,143 +13% 0% $486,643
CIBC Asset Management Inc 0.14% 17,568 0% 0% $424,443
MORGAN STANLEY 0.12% 15,675 -17% 0% $378,709
Nuveen, LLC 0.12% 15,369 -70% 0% $371,315
Abacus Wealth Partners, LLC 0.12% 15,000 0.05% $362,400
NISA INVESTMENT ADVISORS, LLC 0.12% 14,800 0% $357,568
ALLIANCEBERNSTEIN L.P. 0.1% 13,070 0% 0% $315,771
GOLDMAN SACHS GROUP INC 0.1% 12,722 0% $307,364
BARCLAYS PLC 0.1% 12,466 -6.3% 0% $301,178
RHUMBLINE ADVISERS 0.1% 12,206 +8% 0% $294,889
AMERICAN CENTURY COMPANIES INC 0.08% 10,044 0% $242,663

Institutional Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 10,000 $156,200 -$74,976 $15.62 1
2025 Q3 2,353,724 $56,868,048 +$22,987,379 $24.16 58
2025 Q2 1,387,298 $49,914,163 +$34,081,287 $35.98 46
2025 Q1 473,835 $8,469,550 +$8,375,403 $17.88 24
2024 Q4 5,377 $1,773 +$1,773 $0.33 2